Targeting the lipid kinase PIKfyve upregulates surface expression of MHC class I to augment cancer immunotherapyYi Bao, Arul M. Chinnaiyan, Jiali Yu et al.|Proceedings of the National Academy of Sciences|2023Cited by 31
Defining CDK12 as a tumor suppressor and therapeutic target in mouse models of tubo-ovarian high-grade serous carcinomaJean C. Tien, Arul M. Chinnaiyan, Ke Ding et al.|Proceedings of the National Academy of Sciences|2025Cited by 6